← Back to Journal
Buying Guides

The Best Gemstone Investments for 2026: A Clear-Eyed Assessment

Fine gemstones can be excellent stores of value, but only in specific categories with the right documentation at the right price. This is not investment advice, but it is an honest framework for thinking about gems as assets.

The gemstone market has produced extraordinary returns for buyers of the right material at the right time: Kashmir sapphire, Burma ruby and Colombian emerald of exceptional quality have appreciated dramatically over the past thirty years. It has also produced significant losses for buyers who paid retail prices for commercial material, bought stones without documentation, or misjudged liquidity. The honest starting point for any investment framework is that most gemstones are not investment grade. They are luxury items, and luxury items depreciate unless specific conditions are met.

The conditions for investment-grade material

Investment-grade gemstones share several properties: laboratory documentation from major recognised laboratories, origin premium from historically significant deposits (Kashmir, Burma, Colombia), treatment status that drives premium (no heat in corundum is the clearest example), sufficient size to attract collector interest (generally two carats or above for coloured stones), and a sufficiently liquid market to exit at a reasonable price within a reasonable timeframe. All five conditions matter. A stone that satisfies four out of five has significantly diminished investment case.

Kashmir sapphire and unheated Burmese ruby

These two categories have the strongest documented price appreciation of any coloured stone over the past two decades. Kashmir sapphire is supply-constrained by an exhausted deposit. There is no possibility of supply increase. Unheated Burmese ruby is constrained by treatment rates: new Mogok production is increasingly heated as demand for heat-treated ruby grows and the finest unheated material becomes harder to find. Both require Swiss or GIA laboratory documentation; both are illiquid and require specialist dealers to exit correctly; both have consistently appreciated above inflation over thirty-year timeframes.

Colombian emerald with minor treatment

Fine Colombian emerald with minor oil treatment and major laboratory documentation has a reasonable track record of value retention. The key caveat is treatment level: heavily filled emerald does not hold value the way lightly treated or untreated material does. The Colombia origin premium has remained stable while other origins have seen more price volatility. The challenge is liquidity: selling fine emerald quickly without sacrificing significant value requires established relationships with specialist dealers.

What to avoid

Avoid any gemstone marketed primarily on investment narrative without gemmological substance. Avoid blue topaz, treated amethyst, commercial tanzanite and most laboratory-grown stones as investment vehicles. They are enjoyable luxury items but are produced in quantities that preclude meaningful appreciation. Avoid stones without laboratory documentation regardless of the seller’s reputation. Avoid any stone where the purchase price requires the investment thesis to work to justify enjoyment. Buy stones you would want to own even if they never appreciated, and treat the appreciation as a bonus.

← All articles